172 related articles for article (PubMed ID: 37814565)
1. Treatment of recurrent Clostridioides difficile infections with faecal microbiota transplantation: peri-procedural methods in a consecutive case series.
Korpak K; Defourny L; Lali S; Delvallée M; Demeester R; Toussaint E
Acta Gastroenterol Belg; 2023; 86(3):486-489. PubMed ID: 37814565
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
[TBL] [Abstract][Full Text] [Related]
6. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
7. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH
Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337
[TBL] [Abstract][Full Text] [Related]
9. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
10. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P
J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Haber SL; Raney CRK; Larson TL; Lau JP
Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with
Varga A; Makszin L; Bufa A; Sipos D; Kása P; Pál S; Rosenstiel P; Sommer F; Kocsis B; Péterfi Z
Front Cell Infect Microbiol; 2023; 13():1041384. PubMed ID: 36756616
[TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
[TBL] [Abstract][Full Text] [Related]
14. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
[TBL] [Abstract][Full Text] [Related]
16. [Faecal microbiota transplantation for Clostridioides difficile infection].
Waldbaum C; López F; Antelo P; Sorda J
Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
Rode AA; Chehri M; Krogsgaard LR; Heno KK; Svendsen AT; Ribberholt I; Helms M; Engberg J; Schønning K; Tvede M; Andersen CØ; Jensen US; Petersen AM; Bytzer P
Aliment Pharmacol Ther; 2021 May; 53(9):999-1009. PubMed ID: 33694229
[TBL] [Abstract][Full Text] [Related]
18. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
Chauhan A; Apostolov R; van Langenberg D; Garg M
Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantation for treatment of recurrent or refractory
Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
[TBL] [Abstract][Full Text] [Related]
20. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
